WHO grants emergency use listing to Bharat Biotech’s Covaxin

Covaxin gets shelf life extension up to 12 months

Centre’s vaccination scheme has created 2 classes of citizens in India: Kerala HC

Australia formally recognises India’s Covaxin

‘Additional clarifications’ needed from Bharat Biotech to conduct final assessment of Covaxin: WHO

COVID vaccine EUL recommendation process sometimes takes longer: WHO official says as Covaxin decision awaited

WHO’s technical group to meet on Oct 26 to consider emergency use listing of Covaxin

DCGI approves Bharat Biotech’s Covaxin for children in 2-18 age group

Awaiting regulatory approvals to launch Covaxin for children-Bharat Biotech

WHO approval for Covaxin next week?

Decision on Bharat Biotech’s Covaxin EUL in October: WHO

Covishield added to UK travel advisory, but Indians to follow ‘non-vaccinated’ rules

Paediatric Covaxin: Bharat Biotech completes phase 2/3 trials

WHO Experts’ Group to take a call on EUL for Covaxin on October 6

Fake vaccination certificates, test results sold on Telegram for $75: Check Point

WHO’s approval for Covaxin likely this month

Govt panel recommends EUA to Zydus Cadila’s 3-dose COVID-19 vaccine

Over 38 mn people didn’t get 2nd vaccine dose within stipulated time, says govt

India’s drug regulator approves study on mixing of Covaxin and Covishield doses

Covishield, Covaxin combination brings better immunogenicity than 2 doses of same vaccine: Study

Bharat Biotech’s Covaxin effective against Delta Plus variant of COVID-19:Study

After suspending EUA request, Brazil now shelves import authorisation of Covaxin

Brazil suspends Bharat Biotech’s Covaxin clinical trials

Bharat Biotech terminates MoU with Brazilian partners after graft allegations

Bharat Biotech commits to supply 500 Mn doses of Covaxin to Centre for immunisation programme

WHO assessing Covaxin data for EUL; Decision date “to be confirmed”

Decision on emergency use listing of Covaxin likely in 4-6 weeks, says WHO

Final analysis of Covaxin efficacy out; vaccine 65.2 percent effective against Delta variant

Accept Covishield and Covaxin for ‘Green Pass’ or undergo mandatory quarantine: India to EU

Brazil suspends Bharat Biotech’s Covaxin order over graft allegations

Bharat Biotech’s pre-submission meeting for Covaxin EUL with WHO on June 23

Covaxin recipient students being considered as unvaccinated by foreign varsities: ABVP tells Vardhan

Centre rejects reports of dissent by experts about increasing gap between Covishield doses

Social media posts twisted facts, final product doesn’t have newborn calf serum: Centre on Covaxin

Latest Additions

Siddaramaiah says confident of winning all three bypolls in Karnataka

Hop on! IT Minister Priyank Kharge checks out Uber Shuttle at Bengaluru Tech Summit

Actress Kasthuri released from jail, says ‘I thank those who made me raging storm’

Kidnapped for ransom in 1998, 26/11 survivor Gautam Adani faces biggest trial

AIMPLB to hold its annual general sessions in Bengaluru from November 23

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.